These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32862311)

  • 61. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part I. Tumor necrosis factor alpha inhibitors].
    Swierkot J; Madej M
    Pol Merkur Lekarski; 2011 Apr; 30(178):283-8. PubMed ID: 21595176
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritis.
    Timlin H; Bingham CO
    Expert Opin Biol Ther; 2014 Jul; 14(7):893-904. PubMed ID: 24720727
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunomodulation of rheumatologic disorders with non-biologic disease modifying antirheumtic drugs.
    Walker UA
    Semin Hematol; 2016 Apr; 53 Suppl 1():S58-60. PubMed ID: 27312168
    [TBL] [Abstract][Full Text] [Related]  

  • 64. What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?
    Humphreys J; Hyrich K; Symmons D
    Arthritis Res Ther; 2016 Dec; 18(1):282. PubMed ID: 27906042
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.
    Kim SK; Kwak SG; Choe JY
    Medicine (Baltimore); 2020 Feb; 99(9):e19415. PubMed ID: 32118795
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Progress in understanding the safety and efficacy of Janus kinase inhibitors for treatment of rheumatoid arthritis.
    Iwata S; Tanaka Y
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1047-57. PubMed ID: 27253519
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Distribution of Podoplanin in Synovial Tissues in Rheumatoid Arthritis Patients Using Biologic or Conventional Disease-Modifying Anti-Rheumatic Drugs.
    Takakubo Y; Oki H; Naganuma Y; Saski K; Sasaki A; Tamaki Y; Suran Y; Konta T; Takagi M
    Curr Rheumatol Rev; 2017; 13(1):72-78. PubMed ID: 27030253
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012.
    Sato E; Tanaka E; Ochiai M; Shimizu Y; Kobayashi A; Shidara K; Hoshi D; Sugimoto N; Inoue E; Seto Y; Nakajima A; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2015 May; 25(3):350-7. PubMed ID: 25619283
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry.
    Choquette D; Bessette L; Alemao E; Haraoui B; Postema R; Raynauld JP; Coupal L
    Arthritis Res Ther; 2019 Jun; 21(1):138. PubMed ID: 31171024
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasmapheresis therapy in combination with TNF-α inhibitor and DMARDs: A multitarget method for the treatment of rheumatoid arthritis.
    Cheng Y; Yang F; Huang C; Huang J; Wang Q; Chen Y; Du Y; Zhao L; Gao M; Wang F
    Mod Rheumatol; 2017 Jul; 27(4):576-581. PubMed ID: 27830969
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
    Oladapo A; Barner JC; Lawson KA; Novak S; Rascati KL; Richards KM; Harrison DJ
    J Manag Care Spec Pharm; 2014 Jul; 20(7):657-67. PubMed ID: 24967519
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Monotherapy in rheumatoid arthritis.
    Scher JU
    Bull Hosp Jt Dis (2013); 2013; 71(3):204-7. PubMed ID: 24151946
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis.
    Mena-Vázquez N; Godoy-Navarrete FJ; Manrique-Arija S; Aguilar-Hurtado MC; Romero-Barco CM; Ureña-Garnica I; Espildora F; Añón-Oñate I; Pérez-Albaladejo L; Gomez-Cano C; Jimenez-Núñez FG; Padin-Martín MI; Fernández-Nebro A
    Clin Rheumatol; 2021 Jan; 40(1):133-142. PubMed ID: 32557255
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Psoriatic Arthritis: Newer and Older Therapies.
    Chao R; Kavanaugh A
    Curr Rheumatol Rep; 2019 Dec; 21(12):75. PubMed ID: 31865449
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An update on disease modifying antirheumatic drugs.
    Joshi P; Dhaneshwar SS
    Inflamm Allergy Drug Targets; 2014; 13(4):249-61. PubMed ID: 25244345
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.
    Machado MAÁ; Moura CS; Guerra SF; Curtis JR; Abrahamowicz M; Bernatsky S
    Arthritis Res Ther; 2018 Mar; 20(1):60. PubMed ID: 29566769
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tocilizumab efficacy and safety in rheumatoid arthritis patients after inadequate response to disease-modifying anti-rheumatic drugs oranti-tumor necrosis factor.
    Abdulkader OAF; Qushmaq K; Aljishi F
    Ann Saudi Med; 2016; 36(3):190-6. PubMed ID: 27236390
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effectiveness of treatment with biologic- and disease-modifying antirheumatic drugs in rheumatoid arthritis patients in Colombia.
    Machado-Alba JE; Ruiz AF; Machado-Duque ME
    Int J Clin Pract; 2016 Jun; 70(6):506-11. PubMed ID: 27238964
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current and future management approaches for rheumatoid arthritis.
    Breedveld FC
    Arthritis Res; 2002; 4 Suppl 2(Suppl 2):S16-21. PubMed ID: 12110153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.